Skip to main content
Top
Published in: AIDS and Behavior 3/2014

01-03-2014 | Original Paper

Transition to Injection Drug Use: The Role of Initiators

Authors: Nooshin Khobzi Rotondi, Carol Strike, Gillian Kolla, Michael A. Rotondi, Katherine Rudzinski, Tim Guimond, Élise Roy

Published in: AIDS and Behavior | Issue 3/2014

Login to get access

Abstract

Data are limited about the role of initiators in the transition to injection drug use. We examined the prevalence and predictors of giving someone their first injection using baseline data from a study involving 98 injection drug users (IDUs) in Toronto, Canada. Participants were recruited in 2011 using respondent-driven sampling. Findings revealed that 27.4 % (95 % CI 14.7–42.2) of IDUs had ever given anyone their first injection. In the logistic regression analysis, being unemployed and having ever spoken positively about injecting to a non-injector were associated with giving someone their first injection. Furthermore, the odds of initiating non-IDUs increased with the number of years that IDUs had been injecting. Our results provide support for interventions that aim to reduce the initiation of non-IDUs; however, further research is needed to shed light on the link between unemployment and initiation of non-injectors.
Literature
1.
go back to reference van Beek I, Dwyer R, Dore G, Luo K, Kalder JM. Infection with HIV and hepatitis C among injection drug users in a prevention setting: retrospective cohort study. BMJ. 1998;317:433–7.PubMedCentralPubMedCrossRef van Beek I, Dwyer R, Dore G, Luo K, Kalder JM. Infection with HIV and hepatitis C among injection drug users in a prevention setting: retrospective cohort study. BMJ. 1998;317:433–7.PubMedCentralPubMedCrossRef
2.
go back to reference Doherty MC, Garfein RS, Monterroso E, Brown D, Vlahov D. Correlates of HIV infection among young adult short-term injection drug users. AIDS. 2000;14:717–26.PubMedCrossRef Doherty MC, Garfein RS, Monterroso E, Brown D, Vlahov D. Correlates of HIV infection among young adult short-term injection drug users. AIDS. 2000;14:717–26.PubMedCrossRef
3.
go back to reference Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: the prevalence of the Hepatitis C, Hepatitis B, human immunodeficiency, and human T-lymphotrophic viruses. Am J Public Health. 1996;86:655–61.PubMedCentralPubMedCrossRef Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: the prevalence of the Hepatitis C, Hepatitis B, human immunodeficiency, and human T-lymphotrophic viruses. Am J Public Health. 1996;86:655–61.PubMedCentralPubMedCrossRef
4.
go back to reference Cheng Y, Sherman SG, Srirat N, et al. Risk factors associated with injection initiation among drug users in Northern Thailand. Harm Reduct J. 2006;3(10):1–8. Cheng Y, Sherman SG, Srirat N, et al. Risk factors associated with injection initiation among drug users in Northern Thailand. Harm Reduct J. 2006;3(10):1–8.
5.
go back to reference Diaz T, Vlahov D, Edwards V, Conover S, Monterroso E. Sex-specific differences in circumstances of initiation into injecting-drug use among young adult Latinos in Harlem New York City. AIDS Behav. 2002;6(2):117–22.CrossRef Diaz T, Vlahov D, Edwards V, Conover S, Monterroso E. Sex-specific differences in circumstances of initiation into injecting-drug use among young adult Latinos in Harlem New York City. AIDS Behav. 2002;6(2):117–22.CrossRef
6.
go back to reference Feng C, DeBeck K, Kerr T, Mathia S, Montaner J, Wood E. Homelessness independently predicts injection drug use initiation among street-involved youth in a Canadian setting. J Adolesc Health. 2013;52:499–501.PubMedCrossRef Feng C, DeBeck K, Kerr T, Mathia S, Montaner J, Wood E. Homelessness independently predicts injection drug use initiation among street-involved youth in a Canadian setting. J Adolesc Health. 2013;52:499–501.PubMedCrossRef
7.
go back to reference Khobzi N, Strike C, Cavalieri W, et al. A qualitative study on the initiation into injection drug use: necessary and background process. Addict Res Theory. 2009;17(5):546–59.CrossRef Khobzi N, Strike C, Cavalieri W, et al. A qualitative study on the initiation into injection drug use: necessary and background process. Addict Res Theory. 2009;17(5):546–59.CrossRef
8.
go back to reference Miller CL, Strathdee SA, Kerr T, Li K, Wood E. Factors associated with early adolescent initiation into injection drug use: implications for intervention programs. J Adolesc Health. 2006;38:462–4.PubMedCrossRef Miller CL, Strathdee SA, Kerr T, Li K, Wood E. Factors associated with early adolescent initiation into injection drug use: implications for intervention programs. J Adolesc Health. 2006;38:462–4.PubMedCrossRef
9.
go back to reference Roy L, Haley N, Leclerc P, Cédras L, Blais L, Boivin JF. Drug injection among street youths in Montreal: predictors of initiation. J Urban Health. 2003;80(1):92–105.PubMedCentralPubMedCrossRef Roy L, Haley N, Leclerc P, Cédras L, Blais L, Boivin JF. Drug injection among street youths in Montreal: predictors of initiation. J Urban Health. 2003;80(1):92–105.PubMedCentralPubMedCrossRef
10.
go back to reference Roy E, Haley N, Leclerc P, Boudreau J, Boivin J. Risk factors for initiation into drug injection among adolescent street youth. Drugs. 2007;14(5):389–99. Roy E, Haley N, Leclerc P, Boudreau J, Boivin J. Risk factors for initiation into drug injection among adolescent street youth. Drugs. 2007;14(5):389–99.
11.
go back to reference Frajzyngier V, Neaigus A, Gyarmathy A, Miller M, Friedman SR. Gender differences in injection risk behaviors at the first injection episode. Drug Alcohol Depend. 2007;89(2–3):145–52.PubMedCrossRef Frajzyngier V, Neaigus A, Gyarmathy A, Miller M, Friedman SR. Gender differences in injection risk behaviors at the first injection episode. Drug Alcohol Depend. 2007;89(2–3):145–52.PubMedCrossRef
12.
go back to reference Abelson J, Treloar C, Crawford J, Kippax S, Van Beek I, Howard J. Some characteristics of early-onset injection drug users prior to and at the time of their first injection. Addiction. 2006;101(4):548–55.PubMedCrossRef Abelson J, Treloar C, Crawford J, Kippax S, Van Beek I, Howard J. Some characteristics of early-onset injection drug users prior to and at the time of their first injection. Addiction. 2006;101(4):548–55.PubMedCrossRef
13.
go back to reference Fuller CM, Borrell LN, Latkin CA, et al. Effects of race, neighborhood, and social network on age at initiation of injection drug use. Am J Public Health. 2005;95(4):689–95.PubMedCentralPubMedCrossRef Fuller CM, Borrell LN, Latkin CA, et al. Effects of race, neighborhood, and social network on age at initiation of injection drug use. Am J Public Health. 2005;95(4):689–95.PubMedCentralPubMedCrossRef
14.
go back to reference Bryant J, Treloar C. Initiators: an examination of young injecting drug users who initiate others to injecting. AIDS Behav. 2008;12(6):885–90.PubMedCrossRef Bryant J, Treloar C. Initiators: an examination of young injecting drug users who initiate others to injecting. AIDS Behav. 2008;12(6):885–90.PubMedCrossRef
15.
go back to reference Crofts N, Louie R, Rosenthal D, Jolley D. The first hit: circumstances surrounding initiation into injecting. Addiction. 1996;91(8):1187–96.PubMedCrossRef Crofts N, Louie R, Rosenthal D, Jolley D. The first hit: circumstances surrounding initiation into injecting. Addiction. 1996;91(8):1187–96.PubMedCrossRef
16.
go back to reference Day CA, Ross J, Dietze P, Dolan K. Initiation to heroin injecting among heroin users in Sydney, Australia: cross sectional survey. Harm Reduct J. 2005;2(2):1–7. Day CA, Ross J, Dietze P, Dolan K. Initiation to heroin injecting among heroin users in Sydney, Australia: cross sectional survey. Harm Reduct J. 2005;2(2):1–7.
17.
go back to reference Kermode M, Longleng V, Singh BC, Hocking J, Langkham B, Croft N. My first time: initiation into injecting drug use in Manipur and Nagaland, north-east India. Harm Reduct J. 2007;4(19):1–11. Kermode M, Longleng V, Singh BC, Hocking J, Langkham B, Croft N. My first time: initiation into injecting drug use in Manipur and Nagaland, north-east India. Harm Reduct J. 2007;4(19):1–11.
18.
go back to reference Hunt N, Stillwell G, Taylor C, Griffiths P. Evaluation of a brief intervention to prevent initiation into injecting. Drugs. 1998;5(2):185–94. Hunt N, Stillwell G, Taylor C, Griffiths P. Evaluation of a brief intervention to prevent initiation into injecting. Drugs. 1998;5(2):185–94.
19.
go back to reference Stillwell C, Hunt N, Taylor C, Griffiths P. The modeling of injecting behaviour and initiation into injecting. Addict Res Theory. 1999;7(5):447–59.CrossRef Stillwell C, Hunt N, Taylor C, Griffiths P. The modeling of injecting behaviour and initiation into injecting. Addict Res Theory. 1999;7(5):447–59.CrossRef
20.
go back to reference Public Health Agency of Canada. Summary: estimates of HIV prevalence and incidence in Canada, 2011. Cat.: HP37-16/2011E. Surveillance and Epidemiology Division, Professional Guidelines and Public Health Practice Division, Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada. 2012. Public Health Agency of Canada. Summary: estimates of HIV prevalence and incidence in Canada, 2011. Cat.: HP37-16/2011E. Surveillance and Epidemiology Division, Professional Guidelines and Public Health Practice Division, Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada. 2012.
21.
go back to reference Gough K, Karapita S. Facing the future: an innovative response to the urgent HIV/AIDS crisis in Toronto. Casey House; 2011. Gough K, Karapita S. Facing the future: an innovative response to the urgent HIV/AIDS crisis in Toronto. Casey House; 2011.
23.
go back to reference Canadian AIDS Treatment Information Exchange (CATIE). HIV in Canada: trends and issues that affect HIV prevention, care, treatment and support. Cat.: ATI-40227. 2011. Canadian AIDS Treatment Information Exchange (CATIE). HIV in Canada: trends and issues that affect HIV prevention, care, treatment and support. Cat.: ATI-40227. 2011.
24.
go back to reference Public Health Agency of Canada. Hepatitis C in Canada: 2005-2010 surveillance report. Cat.: HP40-70/2012E. Hepatitis C and STI Surveillance and Epidemiology Section, Community Acquired Infections Division, Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada; 2012. Public Health Agency of Canada. Hepatitis C in Canada: 2005-2010 surveillance report. Cat.: HP40-70/2012E. Hepatitis C and STI Surveillance and Epidemiology Section, Community Acquired Infections Division, Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada; 2012.
25.
go back to reference Remis RR, Liu J. Epidemiology of Hepatitis C infection in Ontario, 2010. Ontario HIV Epidemiologic Monitoring Unit, University of Toronto. Prepared for AIDS Bureau, Ontario Ministry of Health and Long-Term Care; 2011. Remis RR, Liu J. Epidemiology of Hepatitis C infection in Ontario, 2010. Ontario HIV Epidemiologic Monitoring Unit, University of Toronto. Prepared for AIDS Bureau, Ontario Ministry of Health and Long-Term Care; 2011.
26.
go back to reference Heckathorn DD. Respondent-driven sampling: a new approach to the study of hidden populations. Soc Probl. 1997;44(2):174–99.CrossRef Heckathorn DD. Respondent-driven sampling: a new approach to the study of hidden populations. Soc Probl. 1997;44(2):174–99.CrossRef
27.
go back to reference Heckathorn DD. Respondent-driven sampling II: deriving valid population estimates from chain-referral samples of hidden populations. Soc Probl. 2002;49(1):11–34.CrossRef Heckathorn DD. Respondent-driven sampling II: deriving valid population estimates from chain-referral samples of hidden populations. Soc Probl. 2002;49(1):11–34.CrossRef
28.
go back to reference Eastwood EA, Birnbaum JM. Physical and sexual abuse and unstable housing among adolescents with HIV. AIDS Behav. 2007;11(6 Suppl):116–27.PubMedCrossRef Eastwood EA, Birnbaum JM. Physical and sexual abuse and unstable housing among adolescents with HIV. AIDS Behav. 2007;11(6 Suppl):116–27.PubMedCrossRef
29.
go back to reference Volz E, Wejnert C, Cameron C, et al. Respondent-driven sampling analysis tool (RDSAT) Version 7.1. Ithaca: Cornell University; 2012. Volz E, Wejnert C, Cameron C, et al. Respondent-driven sampling analysis tool (RDSAT) Version 7.1. Ithaca: Cornell University; 2012.
30.
go back to reference Ramirez-Valles J, Heckathorn DD, Vazquez R, Diaz RM, Campbell RT. The fit between theory and data in respondent-driven sampling: response to Heimer. AIDS Behav. 2005;9(4):409–14.CrossRef Ramirez-Valles J, Heckathorn DD, Vazquez R, Diaz RM, Campbell RT. The fit between theory and data in respondent-driven sampling: response to Heimer. AIDS Behav. 2005;9(4):409–14.CrossRef
31.
go back to reference Salganik MJ, Heckathorn DD. Sampling and estimation in hidden populations using respondent-driven sampling. Sociol Methodol. 2004;34(1):193–240.CrossRef Salganik MJ, Heckathorn DD. Sampling and estimation in hidden populations using respondent-driven sampling. Sociol Methodol. 2004;34(1):193–240.CrossRef
33.
go back to reference Rotondi NK, Bauer GR, Scanlon K, Kaay M, Travers R, Travers A. Depression in female-to-male transgender Ontarians: trans PULSE project. Can J Commun Ment Health. 2011;30(2):135–55. Rotondi NK, Bauer GR, Scanlon K, Kaay M, Travers R, Travers A. Depression in female-to-male transgender Ontarians: trans PULSE project. Can J Commun Ment Health. 2011;30(2):135–55.
34.
go back to reference Katz MH. Multivariable analysis: a practical guide for clinicians. 2nd ed. New York: Cambridge University Press; 2006.CrossRef Katz MH. Multivariable analysis: a practical guide for clinicians. 2nd ed. New York: Cambridge University Press; 2006.CrossRef
35.
go back to reference SAS Institute. SAS software, 9.2. Cary: SAS Institute; 2010. SAS Institute. SAS software, 9.2. Cary: SAS Institute; 2010.
36.
go back to reference Roy E, Haley N, Leclerc P, Cédras L, Boivin JF. Drug injection among street youth: the first time. Addiction. 2002;97(8):1003–9.PubMedCrossRef Roy E, Haley N, Leclerc P, Cédras L, Boivin JF. Drug injection among street youth: the first time. Addiction. 2002;97(8):1003–9.PubMedCrossRef
37.
go back to reference Kral AH, Bluthenthal RN, Erringer EA, Lorvick J, Edlin BR. Risk factors among IDUs who give injections to or receive injections from other drug users. 1999;94(5):675–83.PubMed Kral AH, Bluthenthal RN, Erringer EA, Lorvick J, Edlin BR. Risk factors among IDUs who give injections to or receive injections from other drug users. 1999;94(5):675–83.PubMed
38.
go back to reference Fairbairn N, Wood E, Small W, Stoltz JA, Li K, Kerr T. Risk profile of individuals who provide assistance with illicit drug injections. Drug Alcohol Depend. 2006;82(1):41–6.PubMedCrossRef Fairbairn N, Wood E, Small W, Stoltz JA, Li K, Kerr T. Risk profile of individuals who provide assistance with illicit drug injections. Drug Alcohol Depend. 2006;82(1):41–6.PubMedCrossRef
39.
go back to reference Wood E, Spittal PM, Kerr T, et al. Requiring help injecting as a risk factor for HIV infection in the Vancouver epidemic: implications for HIV prevention. Can J Public Health. 2003;94:355–9.PubMed Wood E, Spittal PM, Kerr T, et al. Requiring help injecting as a risk factor for HIV infection in the Vancouver epidemic: implications for HIV prevention. Can J Public Health. 2003;94:355–9.PubMed
40.
go back to reference Goldsamt LA, Harocopos A, Kobrak P, Jost JJ, Clatts MC. Circumstances, pedagogy and rationales for injection initiation among new drug injectors. J Commun Health. 2010;35:258–67.CrossRef Goldsamt LA, Harocopos A, Kobrak P, Jost JJ, Clatts MC. Circumstances, pedagogy and rationales for injection initiation among new drug injectors. J Commun Health. 2010;35:258–67.CrossRef
41.
go back to reference McElrath K, Harris J. Peer injecting: implications for injecting order and blood borne viruses among men and women who inject heroin. J Subst Use. 2013;18(1):31–45.CrossRef McElrath K, Harris J. Peer injecting: implications for injecting order and blood borne viruses among men and women who inject heroin. J Subst Use. 2013;18(1):31–45.CrossRef
42.
go back to reference Small W, Fast D, Krusi A, Wood E, Kerr T. Social influences upon injection initiation among street-involved youth in Vancouver, Canada: a qualitative study. Subst Abuse Treat Prev Policy. 2009;4(1):1–8.CrossRef Small W, Fast D, Krusi A, Wood E, Kerr T. Social influences upon injection initiation among street-involved youth in Vancouver, Canada: a qualitative study. Subst Abuse Treat Prev Policy. 2009;4(1):1–8.CrossRef
43.
go back to reference Neaigus A, Miller M, Friedman SR, et al. Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors. Addiction. 2001;96(6):847–60.PubMedCrossRef Neaigus A, Miller M, Friedman SR, et al. Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors. Addiction. 2001;96(6):847–60.PubMedCrossRef
Metadata
Title
Transition to Injection Drug Use: The Role of Initiators
Authors
Nooshin Khobzi Rotondi
Carol Strike
Gillian Kolla
Michael A. Rotondi
Katherine Rudzinski
Tim Guimond
Élise Roy
Publication date
01-03-2014
Publisher
Springer US
Published in
AIDS and Behavior / Issue 3/2014
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-013-0693-8

Other articles of this Issue 3/2014

AIDS and Behavior 3/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.